{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T04:46:54Z","timestamp":1777351614006,"version":"3.51.4"},"reference-count":41,"publisher":"Walter de Gruyter GmbH","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,4,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec id=\"j_cclm-2017-0483_s_999_w2aab3b7c12b1b6b1aab1c17b1Aa\">\n                  <jats:title>Background:<\/jats:title>\n                  <jats:p>Acute kidney injury (AKI) in cirrhotic patients may be functional (hepatorenal syndrome [HRS]) or structural (acute tubular necrosis [ATN]). The differentiation between these two conditions remains challenging; no definite biomarker with a clear cutoff value had been declared. miRNAs seem to be attractive innovative biomarkers to identify the nature of kidney injury in cirrhotic patients. This study aimed to investigate the possibility of using miR-21, miR-210 and miR-146a as differentiating markers between HRS and ATN.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2017-0483_s_998_w2aab3b7c12b1b6b1aab1c17b2Aa\">\n                  <jats:title>Methods:<\/jats:title>\n                  <jats:p>This pilot case control study included 50 patients with liver cirrhosis; 25 with HRS and another 25 with ATN beside 30 healthy controls. Real-time qPCR was used to measure the circulating miRNA tested.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2017-0483_s_997_w2aab3b7c12b1b6b1aab1c17b3Aa\">\n                  <jats:title>Results:<\/jats:title>\n                  <jats:p>Higher levels of miR-21 were observed in both ATN and HRS vs. controls with statistically significant difference between ATN and HRS. The means were 9.466\u00b13.21 in ATN, 2.670\u00b11.387 in HRS and 1.090\u00b10.586 in controls. miR-146a and miR-210 were both significantly lower in ATN and HRS compared to controls with statistically significant differences between ATN and HRS. The means of miR-210 were 1.020\u00b10.643, 1.640\u00b10.605 and 3.0\u00b10.532 in ATN, HRS and controls, respectively. The means of miR-146a were 2.543\u00b11.929, 4.98\u00b11.353 and 6.553\u00b10.426 in ATN, HRS and controls, respectively. ROC analyses proved that the three studied mi-RNAs can be used as differentiating biomarkers between ATN and HRS with the best performance observed with mi-21 achieving specificity and sensitivity equal 96%.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec id=\"j_cclm-2017-0483_s_996_w2aab3b7c12b1b6b1aab1c17b4Aa\">\n                  <jats:title>Conclusions:<\/jats:title>\n                  <jats:p>miR-21, miR-210 and miR-146a may be candidate differentiating markers between HRS and ATN in cirrhotic patients.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1515\/cclm-2017-0483","type":"journal-article","created":{"date-parts":[[2018,1,5]],"date-time":"2018-01-05T22:16:32Z","timestamp":1515190592000},"page":"739-747","source":"Crossref","is-referenced-by-count":18,"title":["Circulating miR-21, miR-210 and miR-146a as potential biomarkers to differentiate acute tubular necrosis from hepatorenal syndrome in patients with liver cirrhosis: a pilot study"],"prefix":"10.1515","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9525-1317","authenticated-orcid":false,"given":"Mona Mohamed","family":"Watany","sequence":"first","affiliation":[{"name":"Clinical Pathology Department , Faculty of Medicine , Tanta University Hospital , El Geish Street , Tanta, Gharbia Governorate , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasha Youssef","family":"Hagag","sequence":"additional","affiliation":[{"name":"Internal Medicine , Tanta University, Faculty of Medicine , Tanta , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa Ibrahim","family":"Okda","sequence":"additional","affiliation":[{"name":"Internal Medicine , Tanta University, Faculty of Medicine , Tanta , Egypt"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2018,1,5]]},"reference":[{"key":"2021021220081975916_j_cclm-2017-0483_ref_001_w2aab3b7c12b1b6b1ab2b1b1Aa","unstructured":"World Health Organization. 2015. Available from: http:\/\/www.who.int\/countries\/egy\/en\/. Accessed: 29 June 2017."},{"key":"2021021220081975916_j_cclm-2017-0483_ref_002_w2aab3b7c12b1b6b1ab2b1b2Aa","doi-asserted-by":"crossref","unstructured":"Francoz C, Nadim MK, Durand F. Kidney biomarkers in cirrhosis. J Hepatol 2016;65:809\u201324.","DOI":"10.1016\/j.jhep.2016.05.025"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_003_w2aab3b7c12b1b6b1ab2b1b3Aa","doi-asserted-by":"crossref","unstructured":"Durand F, Valla D. Assessment of the prognosis of cirrhosis: child-pugh versus MELD. J Hepatol 2005;42(Suppl 1):S100\u20137.","DOI":"10.1016\/j.jhep.2004.11.015"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_004_w2aab3b7c12b1b6b1ab2b1b4Aa","doi-asserted-by":"crossref","unstructured":"Angeli P, Gines P, Wong F, Bernardi M, Boyer TD, Gerbes A, et al. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (vol. 62, pg. 968, 2015). J Hepatol. 2015;63:290.","DOI":"10.1016\/j.jhep.2015.04.001"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_005_w2aab3b7c12b1b6b1ab2b1b5Aa","doi-asserted-by":"crossref","unstructured":"Al-Ismaili Z, Palijan A, Zappitelli M. Biomarkers of acute kidney injury in children: discovery, evaluation, and clinical application. Pediatr Nephrol 2011;26:29\u201340.","DOI":"10.1007\/s00467-010-1576-0"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_006_w2aab3b7c12b1b6b1ab2b1b6Aa","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YP, Castro AF, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604\u201312.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_007_w2aab3b7c12b1b6b1ab2b1b7Aa","doi-asserted-by":"crossref","unstructured":"Francoz C, Prie D, AbdelRazek W, Moreau R, Mandot A, Belghiti J, et al. Inaccuracies of creatinine and creatinine-based equations in candidates for liver transplantation with low creatinine: impact on the model for end-stage liver disease score. Liver Transpl 2010;16:1169\u201377.","DOI":"10.1002\/lt.22128"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_008_w2aab3b7c12b1b6b1ab2b1b8Aa","doi-asserted-by":"crossref","unstructured":"Martensson J, Martling CR, Bell M. Novel biomarkers of acute kidney injury and failure: clinical applicability. Br J Anaesth 2012;109:843\u201350.","DOI":"10.1093\/bja\/aes357"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_009_w2aab3b7c12b1b6b1ab2b1b9Aa","doi-asserted-by":"crossref","unstructured":"Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010;11:597\u2013610.","DOI":"10.1038\/nrg2843"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_010_w2aab3b7c12b1b6b1ab2b1c10Aa","unstructured":"miRBase. 2017. Available from: http:\/\/www.mirbase.org\/cgi-bin\/browse.pl?org=hsa. Accessed: 29 June 2017."},{"key":"2021021220081975916_j_cclm-2017-0483_ref_011_w2aab3b7c12b1b6b1ab2b1c11Aa","doi-asserted-by":"crossref","unstructured":"Trionfini P, Benigni A, Remuzzi G. MicroRNAs in kidney physiology and disease. Nat Rev Nephrol 2015;11:23\u201333.","DOI":"10.1038\/nrneph.2014.202"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_012_w2aab3b7c12b1b6b1ab2b1c12Aa","doi-asserted-by":"crossref","unstructured":"Wei QQ, Mi QS, Dong Z. The regulation and function of micrornas in kidney diseases. IUBMB Life 2013;65:602\u201314.","DOI":"10.1002\/iub.1174"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_013_w2aab3b7c12b1b6b1ab2b1c13Aa","doi-asserted-by":"crossref","unstructured":"Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer \u2013 a survey. Biochim Biophys Acta 2007;1775: 181\u2013232.","DOI":"10.1016\/j.bbcan.2006.10.001"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_014_w2aab3b7c12b1b6b1ab2b1c14Aa","doi-asserted-by":"crossref","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008;18:997\u20131006.","DOI":"10.1038\/cr.2008.282"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_015_w2aab3b7c12b1b6b1ab2b1c15Aa","unstructured":"Aguado-Fraile E, Ramos E, Conde E, Rodriguez M, Liano F, Garcia-Bermejo ML. microRNAs in the kidney: Novel biomarkers of Acute Kidney Injury. Nefrologia 2013;33:826\u201334."},{"key":"2021021220081975916_j_cclm-2017-0483_ref_016_w2aab3b7c12b1b6b1ab2b1c16Aa","doi-asserted-by":"crossref","unstructured":"Fan PC, Chen CC, Chen YC, Chang YS, Chu PH. MicroRNAs in acute kidney injury. Hum Genomics 2016;10:29.","DOI":"10.1186\/s40246-016-0085-z"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_017_w2aab3b7c12b1b6b1ab2b1c17Aa","doi-asserted-by":"crossref","unstructured":"Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, Faulhaber-Walter R, et al. Circulating miR-210 predicts survival in critically Ill patients with acute kidney injury. Clin J Am Soc Nephro 2011;6:1540\u20136.","DOI":"10.2215\/CJN.00430111"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_018_w2aab3b7c12b1b6b1ab2b1c18Aa","doi-asserted-by":"crossref","unstructured":"Cantaluppi V, Gatti S, Medica D, Figliolini F, Bruno S, Deregibus MC, et al. Microvesicles derived from endothelial progenitor cells protect the kidney from ischemia-reperfusion injury by microRNA-dependent reprogramming of resident renal cells. Kidney Int 2012;82:412\u201327.","DOI":"10.1038\/ki.2012.105"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_019_w2aab3b7c12b1b6b1ab2b1c19Aa","doi-asserted-by":"crossref","unstructured":"Aguado-Fraile E, Ramos E, Conde E, Rodriguez M, Martin-Gomez L, Lietor A, et al. A pilot study identifying a set of microRNAs as precise diagnostic biomarkers of acute kidney injury. PLoS One 2015;10:e0127175.","DOI":"10.1371\/journal.pone.0127175"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_020_w2aab3b7c12b1b6b1ab2b1c20Aa","doi-asserted-by":"crossref","unstructured":"Godwin JG, Ge XP, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. P Natl Acad Sci USA 2010;107:14339\u201344.","DOI":"10.1073\/pnas.0912701107"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_021_w2aab3b7c12b1b6b1ab2b1c21Aa","doi-asserted-by":"crossref","unstructured":"Jia P, Teng J, Zou JZ, Fang Y, Wu X, Liang MY, et al. Xenon protects against septic acute kidney injury via miR-21 target signaling pathway. Crit Care Med 2015;43:E250\u20139.","DOI":"10.1097\/CCM.0000000000001001"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_022_w2aab3b7c12b1b6b1ab2b1c22Aa","doi-asserted-by":"crossref","unstructured":"Xu XL, Kriegel AJ, Liu Y, Usa K, Mladinov D, Liu H, et al. Delayed ischemic preconditioning contributes to renal protection by upregulation of miR-21. Kidney Int 2012;82:1167\u201375.","DOI":"10.1038\/ki.2012.241"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_023_w2aab3b7c12b1b6b1ab2b1c23Aa","doi-asserted-by":"crossref","unstructured":"Hu HL, Jiang W, Xi XQ, Zou C, Ye ZF. MicroRNA-21 attenuates renal ischemia reperfusion injury via targeting caspase signaling in mice. Am J Nephrol 2014;40:215\u201323.","DOI":"10.1159\/000368202"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_024_w2aab3b7c12b1b6b1ab2b1c24Aa","doi-asserted-by":"crossref","unstructured":"Chau BN, Xin CY, Hartner J, Ren SY, Castano AP, Linn G, et al. MicroRNA-21 promotes fibrosis of the kidney by silencing metabolic pathways. Sci Transl Med 2012;4:121ra18.","DOI":"10.1126\/scitranslmed.3003205"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_025_w2aab3b7c12b1b6b1ab2b1c25Aa","doi-asserted-by":"crossref","unstructured":"Zarjou A, Yang SZ, Abraham E, Agarwal A, Liu G. Identification of a microRNA signature in renal fibrosis: role of miR-21. Am J Physiol-Renal 2011;301:F793\u2013801.","DOI":"10.1152\/ajprenal.00273.2011"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_026_w2aab3b7c12b1b6b1ab2b1c26Aa","doi-asserted-by":"crossref","unstructured":"Denby L, Ramdas V, Lu RF, Conway BR, Grant JS, Dickinson B, et al. MicroRNA-214 antagonism protects against renal fibrosis. J Am Soc Nephrol 2014;25:65\u201380.","DOI":"10.1681\/ASN.2013010072"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_027_w2aab3b7c12b1b6b1ab2b1c27Aa","doi-asserted-by":"crossref","unstructured":"Du J, Cao XQ, Zou L, Chen Y, Guo J, Chen ZJ, et al. MicroRNA-21 and risk of severe acute kidney injury and poor outcomes after adult cardiac surgery. PLoS One 2013;8:e63390.","DOI":"10.1371\/journal.pone.0063390"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_028_w2aab3b7c12b1b6b1ab2b1c28Aa","doi-asserted-by":"crossref","unstructured":"Hartleb M, Gutkowski K. Kidneys in chronic liver diseases. World J Gastroenterol 2012;18:3035\u201349.","DOI":"10.3748\/wjg.v18.i24.3035"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_029_w2aab3b7c12b1b6b1ab2b1c29Aa","unstructured":"Weiss JB, Eisenhardt SU, Stark GB, Bode C, Moser M, Grundmann S. MicroRNAs in ischemia-reperfusion injury. Am J Cardiovasc Dis 2012;2:237\u201347."},{"key":"2021021220081975916_j_cclm-2017-0483_ref_030_w2aab3b7c12b1b6b1ab2b1c30Aa","doi-asserted-by":"crossref","unstructured":"Godwin JG, Ge X, Stephan K, Jurisch A, Tullius SG, Iacomini J. Identification of a microRNA signature of renal ischemia reperfusion injury. Proc Natl Acad Sci USA 2010;107:14339\u201344.","DOI":"10.1073\/pnas.0912701107"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_031_w2aab3b7c12b1b6b1ab2b1c31Aa","doi-asserted-by":"crossref","unstructured":"Banaei S. Novel role of microRNAs in renal ischemia reperfusion injury. Ren Fail 2015;37:1073\u20139.","DOI":"10.3109\/0886022X.2015.1055697"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_032_w2aab3b7c12b1b6b1ab2b1c32Aa","doi-asserted-by":"crossref","unstructured":"Lorenzen JM. Vascular and circulating microRNAs in renal ischaemia\u2013reperfusion injury. J Physiol 2015;593(Pt 8):1777\u201384.","DOI":"10.1113\/JP270318"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_033_w2aab3b7c12b1b6b1ab2b1c33Aa","doi-asserted-by":"crossref","unstructured":"Park KM, Kramers C, Vayssier-Taussat M, Chen A, Bonventre JV. Prevention of kidney ischemia\/reperfusion-induced functional injury, MAPK and MAPK kinase activation, and inflammation by remote transient ureteral obstruction. J Biol Chem 2002;277:2040\u20139.","DOI":"10.1074\/jbc.M107525200"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_034_w2aab3b7c12b1b6b1ab2b1c34Aa","doi-asserted-by":"crossref","unstructured":"Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, Lund AH. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008;283:1026\u201333.","DOI":"10.1074\/jbc.M707224200"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_035_w2aab3b7c12b1b6b1ab2b1c35Aa","doi-asserted-by":"crossref","unstructured":"Kaucsar T, Revesz C, Godo M, Krenacs T, Albert M, Szalay CI, et al. Activation of the miR-17 Family and miR-21 During Murine Kidney Ischemia-Reperfusion Injury. Nucleic Acid Ther 2013;23:344\u201354.","DOI":"10.1089\/nat.2013.0438"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_036_w2aab3b7c12b1b6b1ab2b1c36Aa","doi-asserted-by":"crossref","unstructured":"Denby L, Ramdas V, McBride MW, Wang J, Robinson H, McClure J, et al. miR-21 and miR-214 Are Consistently Modulated during Renal Injury in Rodent Models. Am J Pathol 2011;179:661\u201372.","DOI":"10.1016\/j.ajpath.2011.04.021"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_037_w2aab3b7c12b1b6b1ab2b1c37Aa","doi-asserted-by":"crossref","unstructured":"Saikumar J, Hoffmann D, Kim T-M, Gonzalez VR, Zhang Q, Goering PL, et al. Expression, circulation, and excretion profile of MicroRNA-21, -155, and -18a following acute kidney injury. Toxicol Sci 2012;129:256\u201367.","DOI":"10.1093\/toxsci\/kfs210"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_038_w2aab3b7c12b1b6b1ab2b1c38Aa","doi-asserted-by":"crossref","unstructured":"Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F, et al. Upregulation of MicroRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia\/perfusion injury in vivo and in vitro. Kidney Blood Press Res 2012;35:182\u201391.","DOI":"10.1159\/000331054"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_039_w2aab3b7c12b1b6b1ab2b1c39Aa","doi-asserted-by":"crossref","unstructured":"Cui R, Xu J, Chen X, Zhu WL. Global miRNA expression is temporally correlated with acute kidney injury in mice. Peerj 2016;4:e1729.","DOI":"10.7717\/peerj.1729"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_040_w2aab3b7c12b1b6b1ab2b1c40Aa","doi-asserted-by":"crossref","unstructured":"Meyrier A, Hill GS, Simon P. Ischemic renal diseases: new insights into old entities. Kidney Int 1998;54:2\u201313.","DOI":"10.1046\/j.1523-1755.1998.00968.x"},{"key":"2021021220081975916_j_cclm-2017-0483_ref_041_w2aab3b7c12b1b6b1ab2b1c41Aa","doi-asserted-by":"crossref","unstructured":"Francoz C, Glotz D, Moreau R, Durand F. The evaluation of renal function and disease in patients with cirrhosis. J Hepatol 2010;52:605\u201313.","DOI":"10.1016\/j.jhep.2009.11.025"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2018.56.issue-5\/cclm-2017-0483\/cclm-2017-0483.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0483\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0483\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T23:58:39Z","timestamp":1619049519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0483\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,5]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,1,5]]},"published-print":{"date-parts":[[2018,4,25]]}},"alternative-id":["10.1515\/cclm-2017-0483"],"URL":"https:\/\/doi.org\/10.1515\/cclm-2017-0483","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1,5]]}}}